Value of arterial spin labeling in the clinical imaging protocol of pediatric brain tumors

Value of arterial spin labeling in the clinical imaging protocol of pediatric brain tumors - Non-invasive perfusion imaging in pediatric neuro-oncology

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON35442

Enrollment

120

Registered

2012-02-01

Start date

2012-02-02

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

brain tumor neuro-oncology

Interventions

None listed

Eligibility

Age

2 Years to 17 Years

Inclusion criteria

Inclusion criteria: - 0 to 18 years of age - appointed to undergo a MRI-scan (all cranial MRI-scans during follow-up will be included) - suspected, diagnosed or (previously) treated brain tumor (i.e. cranial central nervous system (CNS)-tumor)

Exclusion criteria

Exclusion criteria: - patients who do not meet the specific inclusion criteria; - contraindications for MRI, such as claustrophobia or the presence of metal in the body; - inability of parents/legal guardians or patients themselves, if older than 12 years of age, to provide informed consent; - refusal by the child of any age before or during the imaging procedure

Design outcomes

Primary

Measure	Time frame
baseline cerebral blood flow, tumor World Health Organization malignancy grade diagnosed by histology.	—

Secondary

Measure	Time frame
cerebral blood flow at follow-up; results of the clinical scans at baseline and follow-up	—

Countries

Netherlands

Outcome results